Zimmer Biomet Holdings Raises FY2026 Adj EPS Guidance from $8.30-$8.45 to $8.40-$8.55 vs $8.40 Est; Affirms FY2026 Sales Guidance of $8.437B-$8.602B vs $8.555B Est

Benzinga Newsdesk www.benzinga.com Positive 78.5%

Neg 0% Neu 0% Pos 78.5%

Zimmer Biomet Holdings (NYSE:ZBH) raises FY2026 Adj EPS guidance from $8.30-$8.45 to $8.40-$8.55 vs $8.40 analyst estimate. Affirms FY2026 sales outlook from $8.437 billion-$8.602 billion to $8.437 billion-$8.602 billion vs $8.555 billion estimate.